AI assistant
Sending…
Predictive Oncology Inc. — Director's Dealing 2015
Apr 28, 2015
35106_dirs_2015-04-28_c5fa2d53-6031-4988-bb9d-89aa439a3f1d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2015-03-31
Reporting Person: Reding Andrew P. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | Stock Option (right to buy) | $3.45 | A | 1449 | Acquired | 2025-03-31 | Common Stock (1449) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $.01 par value | 1314 | Direct |
More from Predictive Oncology Inc.
Capital/Financing Update
2026
Jun 9
Regulatory Filings
2026
Jun 9
Earnings Release
2026
May 15
Capital/Financing Update
2026
May 15
Capital/Financing Update
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 22
Board/Management Information
2026
Apr 16
Board/Management Information
2026
Apr 1